Ni, W <br/><br/>
New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice.  [electronic resource] 

 -  Circulation  Apr 2001 
 - 2096-101 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-7322 
<br/><br/><label>Standard No.: </label>10.1161/01.cir.103.16.2096  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aorta--drug effects<br/>Apolipoproteins E--deficiency<br/>Arteriosclerosis--genetics<br/>Chemokine CCL2--antagonists & inhibitors<br/>Chemotaxis--drug effects<br/>Disease Models, Animal<br/>Disease Progression<br/>Genetic Therapy--methods<br/>Humans<br/>Leukocyte Count<br/>Lipids--blood<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Monocytes--cytology<br/>Muscle, Skeletal--drug effects<br/>Peptide Fragments--genetics<br/>Recombinant Proteins--pharmacology<br/>Sequence Deletion<br/>Skin--cytology<br/>Transfection<br/>Treatment Outcome